Simris Alg AB (publ) (SIMRIS-B) - Total Liabilities
Based on the latest financial reports, Simris Alg AB (publ) (SIMRIS-B) has total liabilities worth Skr148.85 Million SEK (≈ $16.02 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Simris Alg AB (publ) operating cash flow efficiency to assess how effectively this company generates cash.
Simris Alg AB (publ) - Total Liabilities Trend (2012–2025)
This chart illustrates how Simris Alg AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. See Simris Alg AB (publ) (SIMRIS-B) shareholders funds for net asset value and shareholders' equity analysis.
Simris Alg AB (publ) Competitors by Total Liabilities
The table below lists competitors of Simris Alg AB (publ) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ladangbaja Murni PT Tbk
JK:LABA
|
Indonesia | Rp31.52 Billion |
|
Bayan Mining and Minerals Ltd
AU:BMM
|
Australia | AU$310.21K |
|
Jeju Beer Co. Ltd.
KQ:276730
|
Korea | ₩38.35 Billion |
|
Nagambie Resources Ltd
AU:NAG
|
Australia | AU$9.89 Million |
|
FGI Industries Ltd
NASDAQ:FGI
|
USA | $54.60 Million |
|
Click Holdings Limited
NASDAQ:CLIK
|
USA | $20.04 Million |
|
Curis Inc
NASDAQ:CRIS
|
USA | $42.33 Million |
Liability Composition Analysis (2012–2025)
This chart breaks down Simris Alg AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Simris Alg AB (publ) (SIMRIS-B) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.66 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -316.70 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.00 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Simris Alg AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Simris Alg AB (publ) (2012–2025)
The table below shows the annual total liabilities of Simris Alg AB (publ) from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr148.85 Million ≈ $16.02 Million |
-1.69% |
| 2024-12-31 | Skr151.42 Million ≈ $16.29 Million |
+1.66% |
| 2023-12-31 | Skr148.94 Million ≈ $16.03 Million |
-8.45% |
| 2022-12-31 | Skr162.68 Million ≈ $17.51 Million |
+1381.58% |
| 2021-12-31 | Skr10.98 Million ≈ $1.18 Million |
+13.88% |
| 2020-12-31 | Skr9.64 Million ≈ $1.04 Million |
-43.98% |
| 2019-12-31 | Skr17.21 Million ≈ $1.85 Million |
+71.18% |
| 2018-12-31 | Skr10.05 Million ≈ $1.08 Million |
-14.11% |
| 2017-12-31 | Skr11.71 Million ≈ $1.26 Million |
+6.13% |
| 2016-12-31 | Skr11.03 Million ≈ $1.19 Million |
-34.90% |
| 2015-12-31 | Skr16.94 Million ≈ $1.82 Million |
+1461.47% |
| 2014-12-31 | Skr1.08 Million ≈ $116.76K |
+54.44% |
| 2013-12-31 | Skr702.52K ≈ $75.60K |
+10.93% |
| 2012-12-31 | Skr633.30K ≈ $68.15K |
-- |
About Simris Alg AB (publ)
Simris Group AB (PUBL), a biotechnology company, develops, manufactures, and sells bioactive substances from microalgae in Sweden and internationally. It offers skincare products and pharmaceuticals; food ingredients; and Algae Omega-3, an omega-3 EPA and DHA line under the SIMRIS brand name. The company was incorporated in 2011 and is headquartered in Hammenhög, Sweden.